Another study found that 197 of 1471 (13.4%) bladder cancer patients had a low serum albumin level, and low albumin level was independently associated with reduced recurrence-free survival (HR 1.68, P = 0.006) and overall survival (HR 1.93, P < 0.001). This evidence concerns the gene ALB and urinary bladder carcinoma.